The official measles count is up to 121 cases in 17 states, and while there has been much talk about what an awful disease it is and the ramifications of not vaccinating, only a handful of people have talked about costs. Measles is expensive.
The official measles count is up to 121 cases in 17 states, the CDC reported on Monday, and 85% of those resulted from the outbreak stemming from the Disneyland exposure. That’s more cases than were seen in all of 2012—and it’s only February.
Much virtual ink has been spilled in the past several weeks about what an awful disease measles can be, about the impact of irresponsible doctors’ advice, and about the ramifications of not vaccinating on those unable to be vaccinated.
But only a handful of folks have talked about costs. Measles is expensive. Really expensive. And even if you live in a highly vaccinated area with no outbreaks, a measles case in your state—that’s a third of the US right now—still means health department tax dollars diverted from other programs to deal with a disease that was eliminated from the US in 2000.
Read more: http://onforb.es/1B27Air
Source: Forbes
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More